Will Blackstone succeed with Gokaldas and Intelenet?
Forbes India has an article on the Blackstone Group’s investments in India, especially its big bets on textiles firm Gokaldas Exports and BPO firm Intelenet. Blackstone investments in India have…
Fund Raising Alert: Carlyle raises $1-B Asia Fund
Edited extracts from the Press Release: Global private equity firm The Carlyle Group has successfully closed its fourth Asian growth capital fund, Carlyle Asia Growth Partners IV (CAGP IV), a…
Winners & Losers in US Bailout & Bankruptcy Deals
TheDeal.com has an interesting listing starting with the Warren Buffet-Goldman Sachs deal (winner) to Citigroup-Wachovia non-deal (loser, of course). Here are some selections from the Lehman Brothers bankruptcy-related listings: Winners:…
The latest hot Emerging Market for Real Estate investors is…
The USA! That’s according to Tom Shapiro, Founder & President of global real estate investment firm, GoldenTree InSite Partners. Speaking at the Reuters Global Real Estate Summit, Shapiro said that…
MNC Pharma firms step on the gas
Following the buyout of India’s largest pharma firm Ranbaxy by Japan’s Daiichi and RFCL’s animal healthcare business by Pfizer, Businessworld has a cover story on how and why the big…
Cutting banks to size
In an article for the Economic Times, Arun Duggal, the former Indian CEO of Bank of America and a board member of several Indian financial services companies, has a set…
Business Today’s “Cool Companies” List for 2009
Extract from the profile of Kolkata-based branded menswear firm Turtle Limited: Turtle has just reported a turnover of Rs 62 crore, its highest ever, in 2008-09, up from Rs 46…
Same (leftist) baggage in a new package?
In a recent Business Standard column, former Chief Economic Adviser Shankar Acharya has expressed unease – from the perspective of the economy – at the way the new UPA government…
Big Government Is Back!
The new UPA government’s first policy statement – the presidential address (PA) to Parliament – gives Business Standard columnist and former Chief Economic Adviser Shankar Acharya a feeling that this…
Deal Alert: Anjan Drugs to raise Rs. 25-Cr from Evolvence India Life Sciences Fund
Evolvence India Life Sciences Fund (EILSF) has committed to invest upto Rs. 25 Crore in Anjan Drugs Pvt. Ltd., a Chennai-based pharmaceuticals company specializing in medicines to treat Central Nervous…